Whalesbook
This double-digit surge was a direct reaction to the company's robust financial disclosure for the fourth quarter ending December 2025. According to the exchange filing, IGI India reported a net profit of ₹134.6 crore, an 18% year-over-year increase. Revenue climbed 21% to ₹319.7 crore, while earnings before interest, taxes, depreciation, and amortization (EBITDA) grew an even faster 26% to ₹191.3 crore. The market responded with conviction, as trading volume swelled to nearly 19.6 times the two-week average.
Profit Surge Meets Investor Skepticism
Despite the impressive quarterly performance, the broader context for investors remains challenging. The 10% gain only partially recovers from a punishing year that has seen the stock price fall by 36.5%. This decline stands in stark contrast to the Nifty50 benchmark, which advanced over 10% during the same period. The stock's 52-week high is ₹542, a level nearly 70% above its current price, underscoring the depth of the preceding sell-off. This sharp divergence between strong short-term operational results and long-term market underperformance frames the central debate: is the company's strategy finally gaining traction, or is the market right to be cautious?
The Valuation and Sector Divide
A deeper look at the sector reveals a significant valuation gap. Following the price surge, IGI India trades at a price-to-earnings (P/E) ratio of approximately 26. In comparison, jewelry sector leader Titan Company, which posted slower revenue growth in its recent quarter, commands a P/E multiple of over 85. This suggests the market is pricing in substantial risk for IGI, despite its stronger growth metrics. The company's push into the lab-grown diamond certification business, cited by CEO Tehmasp Printer as a source of "strong momentum," may be a point of concern for investors worried about margin compression. The market for lab-grown diamonds in India is expanding rapidly, with export volumes nearly doubling in the last fiscal year, but it is also characterized by falling per-carat prices.
The Lab-Grown Double-Edged Sword
The company's future hinges on its ability to navigate the structural shift in the diamond industry. Management has highlighted increased market share in its traditional natural diamond business alongside growth in the lab-grown segment. While this dual strategy appears robust, the market for lab-grown diamonds saw prices fall by as much as 30% in 2025. The challenge will be to capitalize on the volume growth in synthetic stones without cannibalizing the historically more profitable natural diamond certification services. Analysts see immediate technical resistance for the stock near the ₹320-₹325 level, which coincides with its 50-day moving average. Sustaining a move above this zone will be the first technical proof point for investors that this earnings-driven rally has the potential to reverse the year-long downtrend.